Key result
Aggressive antiplatelet therapy increases bleeding risk, highlighting the need for novel fixed-dose combinations.
Why the study?
There is considerable interest in understanding platelet physiology and developing novel antiplatelet drugs due to the complex role of platelets in vascular ischemic events and the bleeding risks of aggressive therapy.
Design
Review article
Authors
Loading...
May warrant individualized antiplatelet strategies now; leaves open the value of novel therapies and combinations in prospective trials.
This overview highlights the mechanisms of platelet activation and the ongoing need for novel antiplatelet therapies that balance ischemic protection with bleeding risk.
GunduH R Rao (2016) conducted a review in Cardiovascular disease. Antiplatelet therapies was evaluated. Aggressive antiplatelet therapy increases bleeding risk, highlighting the need for novel therapies and fixed-dose combinations for managing chronic cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: